|
|
 |
|
Viewing report
|
|
|
|
China Biotech 2008
General Biologic, Jan 2008, Pages: 79
An executive report on the emerging companies, government incentives and recent investments that are defining China's burgeoning biotech industry. Plus, access to China Biotechnology database!
China Biotech 2008 provides an unprecedented look at biotechnology activities in China. This report provides an in-depth review of the biotech industry mix (service provider, innovators and biogenerics companies), provides an analysis of the Chinese government's role in biotech, and investigates the fundamentals of success and failures present within the commercial enterprise sector.
With China Biotech 2008, you will receive answers and information on the following current events and government activities:
- An overview of the key developments in China over the past year.
- The Bio-industry 'Eleven-Five' Development Program.
- Big pharma makes its mark: AstraZeneca, GSK, Novartis, Merck and others establish R&D presence.
- National bio-industry bases: Status of the 15 bases.
- Key branches of government: The Ministry of Science and Technology; The Chinese Academy of Sciences; The Ministry of Agriculture; The Ministry of Education; The Natural Science Foundation of China; State Food and Drug Administration.
- Intellectual property: central versus local interests; patent laws and regulations; patent statistics; notable recent IP cases.
- Government investment: established investment programs; National Development Bank support; initial investment guide fund for medium and small enterprises; agricultural industries investment.
- Research and education: CAS institutes; universities; national key labs; Bio-Related Institutes of the Chinese Academy of Sciences
Key financial data is also provided on the commercial side of the industry. Access to hard-to-get investment information is available, as well as trend analysis of various sectors and companies. Highlights of these table-focused sections include:
- Major Joint Venture/Wholly Foreign-Owned Enterprises in China
- Comparison of Recent U.S. and China Venture Capital Indicators
- VC Investments in China's Biotech, Pharma Industries
- Chinese Investors
- Intellectual Property Mortgages
- IPO Results Involving Chinese Bio Companies
- Major Trends in China's R&D
- Technology Transfer Characteristics in Beijing's Pharmaceutical Technology Market
- China's Clinical Phase Pipeline
- Outsourcing and Labor Costs
- Salary Data of Chinese Workers in Science/Technology
- Sector Information: agriculture, biologics, antibody, vaccines, industrial, diagnostics
In addition to the data and overview of the different areas of the industry, China Biotech 2008 features five in-depth case studies. These case studies examine the management, technologies, facilities, products, collaborations, strengths and weaknesses of five biotech companies in China and offer a unique insiders view.
Plus: Purchasers of the report will receive free access to a database.
What the database contains:
China Biotech database includes more than 400 of China's biotechnology companies across new drug discovery and development, bio-services, agriculture, and manufacturers of life science related tools and supplies. Information included with the subscription:
I. Company name in English and Chinese
II. Contact information
III. Business scope
VI. Products and services
V.Founding date
China Biotech 2008 is a must-have resource for anyone contemplating doing business in China. Whether your goals are partnering, investing, outsourcing or licensing, this report is imperative if you want the most current information available on the ins-and-outs of this emerging biotech region.
Customers who bought this item also bought
China’s Attraction and Strategies to Work with It: Analysis of Best Strategies for Western Pharmaceutical and Biotech Companies to Partner with Chinese Pharmaceutical Companies
US Biotech Market Analysis
Future of Green Biotechnology in China
The Future of White Biotechnology in China
Biotech 2009-Life Sciences: Navigating the Sea Change
Bio-services in China 2006
Biotechnology in India
Guide to Pharmaceutical Outsourcing in China: A Handbook for Pharmaceutical and Biotechnology Companies Planning to Outsource to China
Biotech Life Sciences: A 20/20 Vision to 2020
Indian Biotech Industry (2005)
Innovative Drug R&D in China
Bio Nanotechnology
|
|
|
|
